Innovation
28 patent families (14 granted) — focus: Human necessities, Operations & transport, Physics & computing; filing pace steady. Cited 3,741 times.
| Year | Filings |
|---|---|
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 7 |
| 2020 | 5 |
| 2021 | 9 |
| 2022 | 12 |
| 2023 | 14 |
| 2024 | 15 |
| 2025 | 16 |
| 2026 | 9 |
Social engagement
Social engagement: 2.2K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
13 investors on record; lead investors include Morningside, Matrix Partners China, CPE, Dalton Venture.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 46% |
| Private equity | 1 | 8% |
| Other / undisclosed | 6 | 46% |
Recent activity
5 Jun 2026
Event
Industrial Insights into Pharmaceutical 3D Printing
27 May 2026
Event
Industrial Insights into Pharmaceutical 3D Printing
31 Mar 2026
Event
15th PBP World Meeting